RSPO3 expression was substantially decreased in HSCs isolated from models of toxic, biliary or MASLD-related liver fibrosis, progressively declining in advanced disease stages, alongside a reduction of RSPO3 protein (Fig. 5a,b and Extended Data Fig. 11a–c). The gene discussed is RSPO3; the disease is metabolic dysfunction-associated steatotic liver disease.